Your browser doesn't support javascript.
loading
Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.
Wills, Christopher; Watts, Katie; Maughan, Timothy S; Fisher, David; Al-Tassan, Nada A; Houlston, Richard S; Escott-Price, Valentina; Cheadle, Jeremy P.
Afiliação
  • Wills C; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Watts K; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Maughan TS; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
  • Fisher D; MRC Clinical Trials Unit, University College of London, London, UK.
  • Al-Tassan NA; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Escott-Price V; Institute of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Cheadle JP; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Genes Chromosomes Cancer ; 62(6): 332-341, 2023 06.
Article em En | MEDLINE | ID: mdl-36790221

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido